13 results on '"Conti, Federico"'
Search Results
2. Mortality among Italians and immigrants with COVID-19 hospitalised in Milan, Italy: data from the Luigi Sacco Hospital registry.
- Author
-
Giacomelli A, Ridolfo AL, Bonazzetti C, Oreni L, Conti F, Pezzati L, Siano M, Bassoli C, Casalini G, Schiuma M, Covizzi A, Passerini M, Piscaglia M, Borgonovo F, Galbiati C, Colombo R, Catena E, Rizzardini G, Milazzo L, Galli M, Brucato A, and Antinori S
- Subjects
- Aged, Hospitals, Humans, Italy epidemiology, Middle Aged, Registries, Retrospective Studies, SARS-CoV-2, COVID-19, Emigrants and Immigrants
- Abstract
Background: To compare differences in the probability of COVID-19-related death between native Italians and immigrants hospitalised with COVID-19., Methods: This retrospective study of prospectively collected data was conducted at the ASST Fatebenefratelli-Sacco Hospital in Milan, Italy, between 21 February and 31 November 2020. Uni- and multivariable Cox proportional hazard models were used to assess the impact of the patients' origin on the probability of COVID-19-related death., Results: The study population consisted of 1,179 COVID-19 patients: 921 Italians (78.1%) and 258 immigrants (21.9%) who came from Latin America (99, 38%), Asia (72, 28%), Africa (50, 19%) and central/eastern Europe (37, 14%). The Italians were significantly older than the immigrants (median age 70 years, interquartile range (IQR) 58-79 vs 51 years, IQR 41-60; p < 0.001), and more frequently had one or more co-morbidities (79.1% vs 53.9%; p < 0.001). Mortality was significantly greater among the Italians than the immigrants as a whole (26.6% vs 12.8%; p < 0.001), and significantly greater among the immigrants from Latin America than among those from Asia, Africa or central/eastern Europe (21% vs 8%, 6% and 8%; p = 0.016). Univariable analysis showed that the risk of COVID-19-related death was lower among the immigrants (hazard ratio [HR] 0.43, 95% confidence interval [CI] 0.30-0.63; p < 0.0001], but the risk of Latin American immigrants did not significantly differ from that of the Italians (HR 0.74, 95% CI 0.47-1.15; p = 0.183). However, after adjusting for potential confounders, multivariable analysis showed that there was no difference in the risk of death between the immigrants and the Italians (adjusted HR [aHR] 1.04, 95% CI 0.70-1.55; p = 0.831), but being of Latin American origin was independently associated with an increased risk of death (aHR 1.95, 95% CI 1.17-3.23; p = 0.010)., Conclusions: Mortality was lower among the immigrants hospitalised with COVID-19 than among their Italian counterparts, but this difference disappeared after adjusting for confounders. However, the increased risk of death among immigrants of Latin American origin suggests that COVID-19 information and prevention initiatives need to be strengthened in this sub-population., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
3. Impact of prior infection status on antibody response to the BNT162b2 mRNA COVID-19 vaccine in healthcare workers at a COVID-19 referral hospital in Milan, Italy.
- Author
-
Milazzo L, Pezzati L, Oreni L, Kullmann C, Lai A, Gabrieli A, Bestetti G, Beschi C, Conti F, Ottomano C, Gervasoni C, Meroni L, Galli M, Antinori S, and Ridolfo AL
- Subjects
- Antibodies, Viral, Antibody Formation, BNT162 Vaccine, Health Personnel, Hospitals, Humans, RNA, Messenger, Referral and Consultation, SARS-CoV-2, Vaccines, Synthetic, mRNA Vaccines, COVID-19 prevention & control, COVID-19 Vaccines
- Abstract
In Italy, SARS-CoV-2 vaccination campaign prioritized healthcare workers (HCWs) to receive two doses of BNT162b2 vaccine, irrespective of a previous SARS-CoV-2 infection. In this real-life study, we compared the humoral response to BNT162b2 vaccine in HCWs with and without a previous SARS-CoV-2 infection. Of the 407 HCWs enrolled, 334 (82.1%) were SARS-CoV-2-naive and 73 (17.9%) SARS-CoV-2-experienced. Post-vaccine humoral response was detectable in more than 98% of HCWs. Overall, the median level of anti-S IgG in SARS-COV-2-experienced HCWs was twice as high as those of SARS-CoV-2-naive subjects (24641.0 AU/mL [IQR: 15273.0->40000.0] versus 13053.8 [IQR: 7303.3-20105.8]; p < .001), irrespective of the time elapsed from SARS-CoV-2 previous infection. In a subgroup of SARS-CoV-2-naive and -experienced subjects who received only one dose of the vaccine, the latter showed 32 times higher levels of anti-S IgG compared to the former. Although no serious adverse events have been reported, mild to moderate side effects occurred more frequently after the first dose in the SARS-CoV-2-experienced than in naive subjects (67% versus 42%, respectively; p < .001). Notably, post-vaccination anti-SARS-CoV-2 spike IgG levels ≥20,000 AU/mL were independently associated with the risk of fever ≥38°C (adjusted odds ratio [aOR] 5.122, 95% CI 2.368-11.080, p < .0001).Our study showed high responsiveness of BNT162b2 vaccine and a relationship between levels of antibody response and reactogenicity. It suggests that a single dose of mRNA vaccine might evoke effective protection in SARS-CoV-2-experienced subjects.
- Published
- 2021
- Full Text
- View/download PDF
4. Brief Report: Impact of the COVID-19 Pandemic on Virological Suppression in People Living With HIV Attending a Large Italian HIV Clinic.
- Author
-
Giacomelli A, Bonazzetti C, Conti F, Pezzati L, Oreni L, Micheli V, Mancon A, Vimercati S, Albrecht M, Passerini M, Cossu MV, Capetti AF, Meraviglia P, Antinori S, Rizzardini G, Galli M, and Ridolfo AL
- Subjects
- Ambulatory Care Facilities, Anti-HIV Agents administration & dosage, Delivery of Health Care methods, HIV Infections drug therapy, HIV-1, Humans, Italy epidemiology, RNA, Viral blood, SARS-CoV-2, Viral Load drug effects, Anti-HIV Agents therapeutic use, COVID-19 complications, COVID-19 epidemiology, HIV Infections complications, HIV Infections epidemiology
- Abstract
Background: We assessed the impact of the coronavirus disease 2019 (COVID-19) pandemic on HIV suppression rates in people living with HIV (PLWH) attending a large Italian HIV clinic., Setting: The HIV outpatient clinic of the Infectious Diseases Department of Luigi Sacco Hospital, Milan, Italy, which serves more than 5000 PLWH per year., Methods: A before and after quasi-experimental study design was used to make a retrospective assessment of the monthly trend of HIV-RNA determinations of ≥50 among the PLWH attending our clinic, with "before" being the period from January 1, 2016 to February 20, 2020, and "after" being the period from February 21, 2020 to December 31, 2020 (the COVID-19 period). Interrupted time series analysis was used to evaluate any changes in the trend., Results: During the study period, 70,349 HIV-RNA viral load determinations were made, and the percentage of HIV-RNA viral load determinations of <50 copies/mL increased from 88.4% in 2016 to 93.2% in 2020 (P < 0.0001). There was a significant monthly trend toward a decrease in the number of HIV-RNA determinations of ≥50 copies/mL before the pandemic (β -0.084; standard error 0.015; P < 0.001), and this did not significantly change after it started (β -0.039, standard error 0.161; P = 0.811)., Conclusions: A high prevalence of viral suppression was maintained among the PLWH referring to our clinic, despite the structural barriers raised by the COVID-19 pandemic. The use of simplified methods of delivering care (such as teleconsultations and multiple antiretroviral treatment prescriptions) may have contributed to preserving this continuum., Competing Interests: The authors have no funding or conflicts of interest to disclose., (Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
5. Differences in the Prevalence of SARS-CoV-2 Infection and Access to Care between Italians and Non-Italians in a Social-Housing Neighbourhood of Milan, Italy.
- Author
-
Pagani G, Conti F, Giacomelli A, Oreni L, Beltrami M, Pezzati L, Casalini G, Rondanin R, Prina A, Zagari A, Rusconi S, and Galli M
- Subjects
- Cross-Sectional Studies, Health Services Accessibility, Housing, Humans, Italy epidemiology, Middle Aged, Pandemics, Prevalence, COVID-19, SARS-CoV-2
- Abstract
The northern Italian region of Lombardy has been severely affected by the COVID-19 pandemic since its arrival in Europe. However, there are only a few published studies of the possible influence of social and cultural factors on its prevalence in the general population. This cross-sectional study of the San Siro social-housing neighbourhood of Milan, which was carried about between 23 December 2020 and 19 February 2021, found that the prevalence of anti-SARS-CoV-2 nucleocapsid antibodies in the population as a whole was 12.4% (253/2044 inhabitants), but there was a more than two-fold difference between non-Italians and Italians (23.3% vs. 9.1%). Multivariable analyses showed that being more than 50 years old, living in crowded accommodation, being a non-Italian, and having a low educational level were associated with higher odds of a positive SARS-CoV-2 test, whereas a higher level of education, retirement, and being a former or current cigarette smoker were inversely associated with SARS-CoV-2 infection. Our findings are in line with previous observations indicating that a lower socio-economic status may be a risk factor for COVID-19 and show that non-Italians are disproportionately affected by SARS-CoV-2 infection. This suggests that public health policies should focus more on disadvantaged populations.
- Published
- 2021
- Full Text
- View/download PDF
6. Detecting HCV infection by means of mass population SARS-CoV-2 screening: A pilot experience in Northern Italy.
- Author
-
Giacomelli A, Pagani G, Conti F, Bassoli C, and Galli M
- Subjects
- Humans, Italy epidemiology, Mass Screening, SARS-CoV-2, COVID-19, Hepatitis C diagnosis, Hepatitis C epidemiology
- Abstract
Competing Interests: Conflict of interest AG has received consultancy fees from Mylan, and educational and grant support from Gilead. MG has received grants and fees for speaker bureaux, advisory boards and CME activities from BMS, ViiV, MSD, AbbVie, Gilead, Janssen and Roche. GP, FC and CB have nothing to declare. Please refer to the accompanying ICMJE disclosure forms for further details.
- Published
- 2021
- Full Text
- View/download PDF
7. A case of extremely prolonged viral shedding: Could cell cultures be a diagnostic tool to drive COVID-19 patient discharge?
- Author
-
Mileto D, Foschi A, Mancon A, Merli S, Staurenghi F, Pezzati L, Rizzo A, Conti F, Romeri F, Bernacchia D, Meroni R, Rizzardini G, Gismondo MR, and Micheli V
- Subjects
- Aged, 80 and over, Cell Culture Techniques, Humans, Male, Patient Discharge, Real-Time Polymerase Chain Reaction, Time Factors, COVID-19 virology, SARS-CoV-2 isolation & purification, Virus Shedding
- Abstract
This study addressed the case of a patient with prolonged COVID-19 viral shedding, reported by Real-Time PCR, until 71 days from symptom onset. However, viral culture received negative results after 30 days from symptom onset. Therefore, viral culture may be a worthwhile test for patients requiring discharge, in particular for those presenting prolonged viral shedding., (Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
8. Prevalence of SARS-CoV-2 in an area of unrestricted viral circulation: Mass seroepidemiological screening in Castiglione d'Adda, Italy.
- Author
-
Pagani G, Giacomelli A, Conti F, Bernacchia D, Rondanin R, Prina A, Scolari V, Rizzo A, Beltrami M, Caimi C, Gandolfi CE, Castaldi S, Rivieccio BA, Buonanno G, Marano G, Ottomano C, Boracchi P, Biganzoli E, and Galli M
- Subjects
- Antibodies, Viral blood, COVID-19 blood, COVID-19 diagnosis, COVID-19 Serological Testing statistics & numerical data, Cross-Sectional Studies, Female, Humans, Immunoglobulin G blood, Immunoglobulin M blood, Italy epidemiology, Male, Mass Screening methods, Prevalence, SARS-CoV-2 genetics, SARS-CoV-2 pathogenicity, COVID-19 epidemiology, COVID-19 transmission, COVID-19 Serological Testing methods
- Abstract
Castiglione D'Adda is one of the municipalities more precociously and severely affected by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) epidemic in Lombardy. With our study we aimed to understand the diffusion of the infection by mass serological screening. We searched for SARS-CoV-2 IgGs in the entire population on a voluntary basis using lateral flow immunochromatographic tests (RICT) on capillary blood (rapid tests). We then performed chemioluminescent serological assays (CLIA) and naso-pharyngeal swabs (NPS) in a randomized representative sample and in each subject with a positive rapid test. Factors associated with RICT IgG positivity were assessed by uni- and multivariate logistic regression models. Out of the 4143 participants, 918 (22·2%) showed RICT IgG positivity. In multivariable analysis, IgG positivity increases with age, with a significant non-linear effect (p = 0·0404). We found 22 positive NPSs out of the 1330 performed. Albeit relevant, the IgG prevalence is lower than expected and suggests that a large part of the population remains susceptible to the infection. The observed differences in prevalence might reflect a different infection susceptibility by age group. A limited persistence of active infections could be found after several weeks after the epidemic peak in the area., Competing Interests: Medispa s.r.l. provided support in the form of salaries for authors RR and AP; Synlab s.p.a. provided support in the form of salaries for author CO. In particular none of the commercial funders (FC Internazionale Milano, Emporio Armani Olimpia Milano, SFD s.p.a. and Banca Mediolanum s.p.a.) had any role in data collection, analysis or intepretation; trial design; patient recruitment; or any aspect pertinent to the study, nor they have any commercial interest (e.g. consultancy, patents, products in development, marketed products, etc). This does not alter our adherence to PLOS ONE policies on sharing data and materials.
- Published
- 2021
- Full Text
- View/download PDF
9. Seroprevalence of SARS-CoV-2 significantly varies with age: Preliminary results from a mass population screening.
- Author
-
Pagani G, Conti F, Giacomelli A, Bernacchia D, Rondanin R, Prina A, Scolari V, Gandolfi CE, Castaldi S, Marano G, Ottomano C, Boracchi P, Biganzoli E, and Galli M
- Subjects
- Antibodies, Viral, France, Humans, Seroepidemiologic Studies, COVID-19, SARS-CoV-2
- Published
- 2020
- Full Text
- View/download PDF
10. Drug–Drug Interactions and Prescription Appropriateness at Hospital Discharge: Experience with COVID-19 Patients.
- Author
-
Cattaneo, Dario, Pasina, Luca, Maggioni, Aldo Pietro, Oreni, Letizia, Conti, Federico, Pezzati, Laura, Casalini, Giacomo, Bonazzetti, Cecilia, Morena, Valentina, Ridolfo, Annalisa, Antinori, Spinello, and Gervasoni, Cristina
- Subjects
COVID-19 ,POLYPHARMACY ,INAPPROPRIATE prescribing (Medicine) ,RISK assessment ,PROTON pump inhibitors ,MEDICATION therapy management ,DRUG interactions ,DESCRIPTIVE statistics ,MEDICATION reconciliation ,HEPARIN ,DISCHARGE planning ,OLD age - Abstract
Background: Patients with coronavirus disease 2019 (COVID-19) are often elderly, with comorbidities, and receiving polypharmacy, all of which are known factors for potentially severe drug–drug interactions (DDIs) and the prescription of potentially inappropriate medications (PIMs). Objective: The aim of this study was to assess the risk of DDIs and PIMs in COVID-19 patients at hospital discharge. Method: Patients with a proven diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection who were hospitalized between 21 February and 30 April 2020, treated with at least two drugs, and with available information regarding pharmacological treatments upon admission and at discharge were considered. The appropriateness of drug prescriptions was assessed using INTERcheck
® . Results: A significant increase in the prescription of proton pump inhibitors and heparins was found when comparing admission with hospital discharge (from 24 to 33% [p < 0.05] and from 1 to 17% [p < 0.01], respectively). The increased prescription of heparins at discharge resulted in a highly significant increase in the potentially severe DDIs mediated by this class of drugs. 51% of COVID-19 patients aged > 65 years had at least one PIM upon admission, with an insignificant increment at discharge (58%). Conclusion: An increased number of prescribed drugs was observed in COVID-19 patients discharged from our hospital. The addition of heparins is appropriate according to the current literature, while the use of proton pump inhibitors is more controversial. Particular attention should be paid to the risk of bleeding complications linked to heparin-based DDIs. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
11. Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS‐CoV‐2 infection: A retrospective cohort study.
- Author
-
Giacomelli, Andrea, Pagani, Gabriele, Ridolfo, Anna L., Oreni, Letizia, Conti, Federico, Pezzati, Laura, Bradanini, Lucia, Casalini, Giacomo, Bassoli, Cinzia, Morena, Valentina, Passerini, Simone, Rizzardini, Giuliano, Cogliati, Chiara, Ceriani, Elisa, Colombo, Riccardo, Rusconi, Stefano, Gervasoni, Cristina, Cattaneo, Dario, Antinori, Spinello, and Galli, Massimo
- Subjects
SARS-CoV-2 ,HYDROXYCHLOROQUINE ,RITONAVIR ,COVID-19 ,COHORT analysis - Abstract
As it has been shown that lopinavir (LPV) and hydroxychloroquine (HCQ) have in vitro activity against coronaviruses, they were used to treat COVID‐19 during the first wave of the epidemic in Lombardy, Italy. To compare the rate of clinical improvement between those who started LPV/ritonavir (LPV/r)+HCQ within 5 days of symptom onset (early treatment, ET) and those who started later (delayed treatment, DT). This was a retrospective intent‐to‐treat analysis of the hospitalized patients who started LPV/r + HCQ between 21 February and 20 March 2020. The association between the timing of treatment and the probability of 30‐day mortality was assessed using univariable and multivariable logistic models. The study involved 172 patients: 43 (25%) in the ET and 129 (75%) in the DT group. The rate of clinical improvement increased over time to 73.3% on day 30, without any significant difference between the two groups (Gray's test P =.213). After adjusting for potentially relevant clinical variables, there was no significant association between the timing of the start of treatment and the probability of 30‐day mortality (adjusted odds ratio [aOR] ET vs DT = 1.45, 95% confidence interval 0.50‐4.19). Eight percent of the patients discontinued the treatment becausebecause of severe gastrointestinal disorders attributable to LPV/r. The timing of the start of LPV/r + HCQ treatment does not seem to affect the clinical course of hospitalized patients with COVID‐19. Together with the severe adverse events attributable to LPV/r, this raises concerns about the benefit of using this combination to treat COVID‐19. Highlights: Lopinavir/ritonavir (LPV/r) plus hydroxychloroquine (HCQ) have been repurposed to treat COVID‐19.We studied the combination of LPV/r plus HCQ in 172 hospitalised patients with COVID‐19.Early LPV/r plus HCQ treatment was not associated with a faster improvement in the patients clinical condition.Early LPV/r plus HCQ treatment did not reduce 30‐day mortality.Eight percent of the patients discontinued the treatment due to severe adverse events. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
12. Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study.
- Author
-
Giacomelli, Andrea, Pezzati, Laura, Conti, Federico, Bernacchia, Dario, Siano, Matteo, Oreni, Letizia, Rusconi, Stefano, Gervasoni, Cristina, Ridolfo, Anna Lisa, Rizzardini, Giuliano, Antinori, Spinello, and Galli, Massimo
- Subjects
SMELL disorders ,TASTE disorders ,COVID-19 - Published
- 2020
- Full Text
- View/download PDF
13. Darunavir does not prevent SARS-CoV-2 infection in HIV patients.
- Author
-
Riva, Agostino, Conti, Federico, Bernacchia, Dario, Pezzati, Laura, Sollima, Salvatore, Merli, Stefania, Siano, Matteo, Lupo, Angelica, Rusconi, Stefano, Cattaneo, Dario, and Gervasoni, Cristina
- Subjects
- *
SARS-CoV-2 , *HIV-positive persons , *COVID-19 - Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.